Please provide your email address to receive an email when new articles are posted on . Men prescribed long-acting testosterone undecanoate injections had a higher adherence to therapy at 1 year ...
Please provide your email address to receive an email when new articles are posted on . Testosterone undecanoate injected at 8-week intervals for men with hypogonadism may reduce fluctuations and ...
NEW YORK (Reuters Health) - A new oral testosterone undecanoate formulation can restore testosterone concentrations to normal in hypogonadal men, researchers report. "Effective as other testosterone ...
SAN DIEGO -- Long-term testosterone therapy was associated with sustained reductions in weight for men with hypogonadism and class III obesity, a researcher reported. In registry data on 76 patients, ...
MIAMI -- Oral testosterone replacement therapy (TRT) seemed safe and effective in men with testosterone deficiency, according to a meta-analysis. Among nine studies that looked at changes in serum ...
The FDA has approved Kyzatrex (testosterone undecanoate) for the treatment of primary and secondary hypogonadism in adult males. The Food and Drug Administration (FDA) has approved Kyzatrex ™ ...
The approval was based on data from a phase 3 study that evaluated the efficacy and safety of Tlando in 95 adult hypogonadal male patients. The Food and Drug Administration (FDA) has approved Tlando™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results